FDA Staff Questions Value of Breast Implant Data (Reuters)


Reuters - New data from Inamed Corp. and rival
Mentor Corp. on their silicone gel breast implants are of
"limited value" in gauging the risk of ruptures, U.S.
regulatory staff said in reports made public on Wednesday.

Read more...